An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer. [electronic resource]
- Medicine Oct 2018
- e12660 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
1536-5964
10.1097/MD.0000000000012660 doi
Afatinib Carcinoma, Non-Small-Cell Lung--drug therapy Disease-Free Survival Drug Resistance, Neoplasm--drug effects ErbB Receptors--genetics Gefitinib Humans Lung Neoplasms--drug therapy Prospective Studies Protein Kinase Inhibitors--pharmacology Proteomics Quinazolines--pharmacology Research Design